Autoimmunity Meets Innovation: Drugs and Devices

The symposium titled Autoimmunity Meets Innovation: Drugs and Devices is set to convene in New York, bringing together a diverse array of leading researchers, clinicians, and industry innovators focused on the advancement of therapies for autoimmune diseases. With 23 million individuals in the United States living with such conditions, the need for innovative treatments is critical.

Current therapies often provide only partial relief and come with considerable side effects due to their broad immunosuppressive effects. This event aims to address these challenges by showcasing groundbreaking research and exploring new intervention strategies that promise to enhance disease management for autoimmune conditions.

Attendees can expect an engaging program that includes keynote lectures and plenary talks from esteemed speakers in the field. The event will feature industry updates, short talks selected from submitted abstracts, and a dynamic panel discussion that encourages interaction and collaboration among participants. Networking opportunities will be plentiful, allowing attendees to connect with peers and leaders who are shaping the future of autoimmune disease treatment.

Furthermore, the symposium aligns with the mission of The New York Academy of Sciences, which is dedicated to driving innovative solutions to societal challenges through scientific research and education. This includes the publication of the Annals of the New York Academy of Sciences, a prominent international journal, and the Blavatnik Awards for Young Scientists, which recognizes and supports the achievements of emerging scientists.

This event promises to be a pivotal gathering for those dedicated to advancing research and therapy in the realm of autoimmune diseases.